Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Non-Alcoholic Steatohepatitis Therapeutics Pipeline Review 2016 - Research and Markets

Research and Markets
Posted on: 25 Aug 16

Research and Markets has announced the addition of the "Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2016" drug pipelines to their offering.

This report provides comprehensive information on the therapeutic development for Non-Alcoholic Steatohepatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Non-Alcoholic Steatohepatitis and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Non-Alcoholic Steatohepatitis Overview
  3. Therapeutics Development
  4. Pipeline Products for Non-Alcoholic Steatohepatitis - Overview
  5. Pipeline Products for Non-Alcoholic Steatohepatitis - Comparative Analysis
  6. Non-Alcoholic Steatohepatitis - Therapeutics under Development by Companies
  7. Non-Alcoholic Steatohepatitis - Therapeutics under Investigation by Universities/Institutes
  8. Non-Alcoholic Steatohepatitis Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Non-Alcoholic Steatohepatitis - Products under Development by Companies
  13. Non-Alcoholic Steatohepatitis - Products under Investigation by Universities/Institutes
  14. Non-Alcoholic Steatohepatitis - Companies Involved in Therapeutics Development(Partial List)
  • Akarna Therapeutics Ltd.
  • AlbireoPharma
  • Alnylam Pharmaceuticals, Inc.
  • Amunix Operating Inc.
  • Aquinox Pharmaceuticals Inc.
  • Arisaph Pharmaceuticals, Inc.
  • AstraZeneca Plc
  • BiOrion Technologies B.V.
  • Bird Rock Bio, Inc.
  • Boehringer Ingelheim GmbH

For more information about this drug pipelines visit

Related Topics: Liver and Kidney Disorders Drugs

View source version on

Business Wire

Last updated on: 25/08/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.